The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
Abstract
Because osteoblasts and marrow adipocytes are derived from a common mesenchymal progenitor, increased adipogenesis may occur at the expense of osteoblasts, leading to bone loss. Our previous in vitro studies indicated that activation of the proadipogenic transcription factor peroxisome proliferator-activated receptor isoform gamma 2 with rosiglitazone suppressed osteoblast differentiation. Here, we show that 5-month-old Swiss-Webster mice receiving rosiglitazone for 28 d exhibited bone loss associated with an increase in marrow adipocytes, a decrease in the ratio of osteoblasts to osteoclasts, a reduction in bone formation rate, and a reduction in wall width--an index of the amount of bone formed by each team of osteoblasts. Rosiglitazone had no effect on the number of early osteoblast or osteoclast progenitors, or on osteoblast life span, but decreased the expression of the key osteoblastogenic transcription factors Runx2 and Osterix in cultures of marrow-derived mesenchymal progenitors. These effects were associated with diversion of bipotential progenitors from the osteoblast to the adipocyte lineage, and suppression of the differentiation of monopotential osteoblast progenitors. However, rosiglitazone had no effect on osteoblastic cells at later stages of differentiation. Hence, rosiglitazone attenuates osteoblast differentiation and thereby reduces bone formation rate in vivo, leading to bone loss. These findings provide a mechanistic explanation for the recent evidence that peroxisome proliferator-activated receptor isoform gamma activation is a negative regulator of bone mass and suggest that the increased production of oxidized fatty acids with age may indeed be an important mechanism for age-related osteoporosis in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Self-citationLehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Inhibition of Adipogenesis by Wnt Signaling
Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., & MacDougald, O. A. (2000) · Science · doi:10.1126/science.289.5481.950 · Cited by 1,874
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1×
“Variables were measured and reported as previously described (23, 25, 26) using the terminology recommended by the Histomorphometry Nomenclature Committee of American Society for Bone and Mineral Research (27).”
MethodSelf-citationParfitt, A. M., Mathews, C. H., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,545
Self-citationDesign of Experiments: Statistical Principles of Research Design and Analysis
Kuehl, R. O. (1999) · Cited by 908
PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U.-I., Kubota, N., Terauchi, Y., Harada, Y., Azuma, Y., Nakamura, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19900 · Cited by 869
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis
Justesen, J., Stenderup, K., Ebbesen, E. N., Mosekilde, L., Steiniche, T., & Kassem, M. (2001) · Biogerontology · doi:10.1023/a:1011513223894 · Cited by 840
MEUNIER, P., AARON, J., EDOUARD, C., & VlGNON, G. (1971) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197110000-00021 · Cited by 779
A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M., & Karsenty, G. (1999) · Genes & Development · doi:10.1101/gad.13.8.1025 · Cited by 774
Bone Loss and Bone Turnover in Diabetes
Krakauer, J. C., Mckenna, M. J., Fenn Buderer, N., Rao, D. S., Whitehouse, F. W., & Parfitt, A. M. (1995) · Diabetes · doi:10.2337/diab.44.7.775 · Cited by 498
Self-citationInhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.
Lecka‐Czernik, B., Gubrij, I. B., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., & Jilka, R. L. (1999) · PubMed · Cited by 464
Self-citationBone Is a Target for the Antidiabetic Compound Rosiglitazone
Rzonca, S. O., Suva, L. J., Gaddy, D., Montague, D. C., & Lecka-Czernik, B. (2004) · Endocrinology · doi:10.1210/en.2003-0746 · Cited by 454
Lecka-Czernik, B., Moerman, E. J., Grant, D. F., Lehmann, J. M., Manolagas, S. C., & Jilka, R. L. (2002) · Endocrinology · doi:10.1210/endo.143.6.8834 · Cited by 441
Self-citationTranscriptional control of osteoblast growth and differentiation
Stein, G. S., Lian, J. B., Stein, J. L., Van Wijnen, A. J., & Montecino, M. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.593 · Cited by 439
Aortic calcification and the risk of osteoporosis and fractures.
Schulz, E., Arfai, K., Liu, X., Sayre, J., & Gilsanz, V. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030964 · Cited by 429
Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age
Lips, P., Courpron, P., & Meunier, P. J. (1978) · Calcified Tissue Research · doi:10.1007/bf02013227 · Cited by 411
Bellido, T., Ali, A. A., Plotkin, L. I., Fu, Q., Gubrij, I., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307444200 · Cited by 378
Self-citationRen, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362
De Vos, P., Lefebvre, A. M., Miller, S. G., Guerre-Millo, M., Wong, K., Saladin, R., Hamann, L. G., Staels, B., Briggs, M. R., & Auwerx, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118860 · Cited by 357
Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118600 · Cited by 339
Self-citationRegulation of Bone Mass in Mice by the Lipoxygenase Gene Alox15
Klein, R. F., Allard, J., Avnur, Z., Nikolcheva, T., Rotstein, D., Carlos, A. S., Shea, M., Waters, R. V., Belknap, J. K., Peltz, G., et al. (2004) · Science · doi:10.1126/science.1090985 · Cited by 296
Cantello, B. C. C., Cawthorne, M. A., Cottam, G. P., Duff, P. T., Haigh, D., Hindley, R. M., Lister, C. A., Smith, S. A., & Thurlby, P. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00049a017 · Cited by 267
Genetic Analysis of Adipogenesis through Peroxisome Proliferator-activated Receptor γ Isoforms
Mueller, E., Drori, S., Aiyer, A., Yie, J., Sarraf, P., Chen, H., Hauser, S., Rosen, E. D., Ge, K., Roeder, R. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206950200 · Cited by 246
Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K., Parfitt, A. M., Jilka, R. L., Manolagas, S. C., & Lipschitz, D. A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1772 · Cited by 231
Self-citationFu, Q., Jilka, R. L., Manolagas, S. C., & O'Brien, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208494200 · Cited by 227
Self-citationRosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis
Sorocéanu, M. A., Miao, D., Bai, X.-Y., Su, H., Goltzman, D., & Karaplis, A. C. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05723 · Cited by 199
Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam study
Stolk, R. P., Van Daele, P. L. A., Pols, H. A. P., Burger, H., Hofman, A., Birkenhäger, J. C., Lamberts, S. W. J., & Grobbee, D. E. (1996) · Bone · doi:10.1016/8756-3282(96)00079-8 · Cited by 194
Mesenchymal Stem Cells and Osteoblast Differentiation
Aubin, J. E. (2008) · Principles of Bone Biology · doi:10.1016/b978-0-12-373884-4.00026-4 · Cited by 190
Hanley, D., Brown, J., Tenenhouse, A., Olszynski, W., Ioannidis, G., Berger, C., Prior, J., Pickard, L., Murray, T., Anastassiades, T., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.4.784 · Cited by 167
Tai, T.-A. C., Jennermann, C., Brown, K. K., Oliver, B. B., MacGinnitie, M. A., Wilkison, W. O., Brown, H. R., Lehmann, J. M., Kliewer, S. A., Morris, D. C., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29909 · Cited by 154
Gregorio, G. B. D., Yamamoto, M., Ali, A., Abe, E., Roberson, P. K., Manolagas, S. C., & Jilka, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11653 · Cited by 127
Self-citationWeinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
Self-citationNosjean, O., & Boutin, J. A. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00281-9 · Cited by 121
Mbalaviele, G., Abu‐Amer, Y., Meng, A., Jaiswal, R. K., Beck, S., Pittenger, M. F., Thiede, M. A., & Marshak, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14388 · Cited by 113
Lunt, M., Masaryk, P., Scheidt-Nave, C., Nijs, J., Poor, G., Pols, H., Falch, J. A., Hammermeister, G., Reid, D. M., Benevolenskaya, L., et al. (2001) · Osteoporosis International · doi:10.1007/s001980170069 · Cited by 112
Thiazolidinediones Inhibit Osteoclast-Like Cell Formation and Bone Resorption in Vitro1
Okazaki, R., Toriumi, M., Fukumoto, S., Miyamoto, M., Fujita, T., TANAKA, K., & Takeuchi, Y. (1999) · Endocrinology · doi:10.1210/endo.140.11.7116 · Cited by 105
The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice
Weinstein, R. S., Jia, D., Powers, C. C., Stewart, S. A., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2004) · Endocrinology · doi:10.1210/en.2003-1133 · Cited by 92
Self-citationPeroxidation of linoleic acid and its relation to aging and age dependent diseases
Spiteller, G. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00220-2 · Cited by 77
PPARs and LXRs: atherosclerosis goes nuclear
Barish, G. D., & Evans, R. M. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.003 · Cited by 77
Kveiborg, M., Sabatakos, G., Chiusaroli, R., Wu, M., Philbrick, W. M., Horne, W. C., & Baron, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2820-2830.2004 · Cited by 74
Fu, M., Zhang, J., Lin, Y. G., Zhu, X., Willson, T. M., & Chen, Y. E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00533-8 · Cited by 62
Watanabe, S. T., Takeuchi, Y., Fukumoto, S., Fujita, H. M., Nakano, T., & Fujita, T. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740300026 · Cited by 56
Okazaki, R., Miura, M., Toriumi, M., et al. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.795 · Cited by 55
Jilka, R. L. (1986) · Bone · doi:10.1016/8756-3282(86)90149-3 · Cited by 36
Self-citationInsulin‐sensitizing action of rosiglitazone is enhanced by preventing hyperphagia
Pickavance, L. C., Buckingham, R. E., & Wilding, J. P. H. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00120.x · Cited by 25
Cited by
Adipocyte differentiation from the inside out
Rosen, E. D., & MacDougald, O. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2066 · Cited by 2,607
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Self-citationFeige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Jilka, R. L. (2007) · Bone · doi:10.1016/j.bone.2007.03.017 · Cited by 720
Self-citation
Metadata
- Authors
- Ali, A. A., Weinstein, R. S., Stewart, S. A., Parfitt, A. M., Manolagas, S. C., & Jilka, R. L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-03
- Volume
- 146
- Issue
- 3
- Pages
- 1226-1235
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2157222091
- Cited by
- 444
- References
- 50
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.